Replies to post #112285 on Avid Bioservices Inc (CDMO)

[pphmtoolong]

I sure hope your rosy scenario plays out. The pancreatic trial data should not have been such a surprise, but it did push the share price back below $2.

Until we get above $2, talk of $10 or more seems premature at best. No harm in dreaming I guess.

GLTA

Paul